Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Short term Debt: 2013-2025

Historic Short term Debt for Rockwell Medical (RMTI) over the last 8 years, with Sep 2025 value amounting to $1.8 million.

  • Rockwell Medical's Short term Debt fell 20.84% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 20.84%. This contributed to the annual value of $2.4 million for FY2024, which is 5.16% down from last year.
  • Latest data reveals that Rockwell Medical reported Short term Debt of $1.8 million as of Q3 2025, which was down 28.00% from $2.5 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Short term Debt ranged from a high of $21.1 million in Q2 2021 and a low of $171,000 during Q1 2021.
  • Moreover, its 3-year median value for Short term Debt was $2.5 million (2025), whereas its average is $2.9 million.
  • Its Short term Debt has fluctuated over the past 5 years, first spiked by 11,046.10% in 2021, then slumped by 77.90% in 2022.
  • Quarterly analysis of 5 years shows Rockwell Medical's Short term Debt stood at $7.4 million in 2021, then plummeted by 77.90% to $1.6 million in 2022, then skyrocketed by 53.28% to $2.5 million in 2023, then decreased by 5.16% to $2.4 million in 2024, then dropped by 20.84% to $1.8 million in 2025.
  • Its Short term Debt was $1.8 million in Q3 2025, compared to $2.5 million in Q2 2025 and $2.4 million in Q1 2025.